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In a recent opinion article (1), we incor-
rectly stated that to date no cases of gen-
der dysphoria had been reported in 46,XX
individuals with adrenogenital syndrome
raised as females. Reflecting on this state-
ment prompted this review.
In a review by Dessens et al. in 2005
(2), 13 of 250 (5.2%) cases of females
with congenital adrenal hyperplasia (CAH)
assigned the female gender role early in life
later exhibited gender dysphoria of such
severity that induced them to seek gen-
der reassignment to male. Of interest, those
cases originate from two publications (3,
4). A review of PubMed under the head-
ings CAH and gender dysphoria yielded
only one more article since 2005 (5).
This information is crucial to aid clini-
cians in counseling parents of affected new-
borns in gender assignment. According to
the American Psychiatric Association, gen-
der dysphoria is defined as a marked dif-
ference between expressed or experienced
gender of a person and the gender that
others would assign him or her, which con-
tinues for 6 months or longer (see www.
dsm5.org).
It is well known that girls with salt wast-
ing CAH tend to exhibit more tomboy-
ish behavior and in adulthood may have
less heterosexual preferences and may be
less comfortable with their femininity.
However, we were interested in finding
out how many cases of XX individuals
with CAH who actually decided to change
their gender role after puberty have been
reported, since this information is impor-
tant for clinicians to advise parents in the
neonatal period.
We thought it worthwhile analyzing
the reported cases in detail. In Table 1
of Dessens et al.’s article, two cases are
listed that were assigned the female gen-
der at birth and in adulthood they iden-
tify themselves and live as males. Both
of these patients were extracted from a
1996 report by Meyer-Bahlburg et al. (3).
In this article, four XX individuals with
CAH who were assigned the female gen-
der in the first few weeks of life and
in adulthood have a male gender iden-
tity and live as males. Two were compli-
ant with glucocorticoid replacement ther-
apy and two were not. It is impossible to
know from the data presented if in the
two compliant patients, the dose was suffi-
cient to suppress production of androgenic
precursors.
Another article reporting cases of gen-
der dysphoria in CAH patients with XX
phenotype is by Woelfle et al. (4). In a
survey of German endocrinologists, they
discovered 16 individuals with XX kary-
otype with “complete virilization” with an
initially missed diagnosis who were raised
as males. Six of them were reassigned to
female in the first 19 months of life and
they all maintain female gender role. Ten
patients were diagnosed after 3 years of
age. In seven patients, the male gender
was maintained with apparently only one
expressing doubts about gender identity. In
three cases of late gender, reassignment to
female was poorly tolerated in 1 of them.
Of course, with good neonatal care,
Woelfle et al.’s series should have only his-
torical interest in the developed world since
all apparently male newborns with bilateral
non-palpable testes should be emergently
evaluated for possible CAH with karyotype
and hormonal studies.
In a family from Saudi Arabia reported
by Bin-Abbas et al. (5), three siblings with
XX karyotype and CAH were raised as
males. One exhibited problems with the
male gender identity and change to female
while the other two continued in their male
gender role.
Zucker et al. (6) compared 31 patients
with CAH with a control group. The
authors concluded that the two groups“did
not differ in degree of gender dyspho-
ria in adulthood, although the probands
showed more cross-gender role identifica-
tion.” Three individuals who did not par-
ticipate in the study lived as males. Two
of them had been assigned the male gen-
der at birth and one changed after puberty.
Details of the hormonal status and com-
pliance with the replacement therapy were
not given.
Schober et al. (7) report includes one XX
individual with salt wasting CAH whose
history and hormonal status are not quite
clear. Her gender identity was intersexual;
sexual orientation was female with homo-
sexual preferences. She had been assigned
the male gender but identifies herself as
female with homosexual preferences.
Gender role and gender dysphoria are
a complex issue and are beyond the scope
of this article. However, from a pediatric
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practitioner viewpoint, faced with new-
born girls with CAH, the information pro-
vided in this review may prove helpful in
counseling parents.
From this review we conclude that:
1. Gender dysphoria has been reported in
XX individuals with CAH assigned the
female gender at birth.
2. It is not clear if the cause of the gen-
der dysphoria in the reported cases
was due to exposure of the fetal brain
to androgens or to poor compliance
with glucocorticoid replacement ther-
apy later in life.
3. In fact, severe gender dysphoria lead-
ing to gender change in adulthood was
reported in only a few individuals diag-
nosed at birth and assigned the female
gender, some of whom did not have
glucocorticoid replacement.
4. Long term endocrine follow up of
females with CAH is mandatory to pre-
vent late virilization due to poor compli-
ance with replacement steroid therapy.
5. The published data available cast serious
doubts on the suggestion by Lee et al. (8)
that severely virilized newborn females
with CAH be raised as males.
6. All newborns with an apparently nor-
mal penis but non-palpable testes
should be immediately evaluated for
possible CAH and assigned the female
gender if the diagnosis of 46,XX CAH is
established.
7. We stand by the recommendations
made in our earlier paper that genito-
plasty should be done in first stage in
the first year of life (1).
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